Venous Thrombosis After Removal of Central Venous Catheter

Status Not yet recruiting

Clinical Trial Summary

Insertion of intravenous catheter is a very common operation in patients in the general intensive care unit. These catheters are used for a variety of purposes - administration of inotropics/pressors, intravenous nutrition, concentrated electrolytes and performing dialysis.There are several known complications of central venous catheter insertion, such as thrombosis and pulmonary embolism. In a literature review, there are no clear data regarding the rate of intravenous thrombosis in patients after removal of a central venous catheter. These findings are often discovered randomly, when the patient undergoes imaging for a different indication. There is no recommendation for an active search for intravenous thrombi at the catheter insertion sites in these patients, and it is not entirely clear whether it is mandatory to administer anticoagulant treatment in these patients if thrombi are randomly discovered at the catheter insertion sites. In this study, we aim to check the proportion of patients who developed thrombosis at the central catheter insertion sites after its removal, to check whether there are catheter insertion sites that are at a higher risk of developing thrombosis than other sites, and to check whether there are predictive characteristics for the development of this type of thrombosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06349291
Study type	Observational
Source	Meir Medical Center
Contact
Status	Not yet recruiting
Phase
Start date	August 1, 2024
Completion date	August 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04503135` - Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit
Completed	`NCT01691495` - ARIXTRA® Adherence in SVT Patients.	N/A
Not yet recruiting	`NCT06149533` - Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients	Phase 3
Active, not recruiting	`NCT05396157` - Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
Completed	`NCT00312013` - Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer	Phase 3
Not yet recruiting	`NCT06288906` - Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems
Completed	`NCT00443053` - Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)	Phase 3
Completed	`NCT00911157` - The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients	Phase 3
Completed	`NCT00320398` - Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)	Phase 3
Completed	`NCT01064362` - Hemorrhage Risk Prescribed Arixtra	N/A
Completed	`NCT01444612` - Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery	N/A
Recruiting	`NCT05710705` - Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast Reconstruction	N/A
Completed	`NCT00843492` - A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery	Phase 3
Recruiting	`NCT06094387` - The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients